BioXcel Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BTAI and other ETFs, options, and stocks.

About BTAI

BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions. 

CEO
Vimal D. Mehta
CEOVimal D. Mehta
Employees
37
Employees37
Headquarters
New Haven, Connecticut
HeadquartersNew Haven, Connecticut
Founded
2017
Founded2017
Employees
37
Employees37

BTAI Key Statistics

Market cap
8.78M
Market cap8.78M
Price-Earnings ratio
-0.11
Price-Earnings ratio-0.11
Dividend yield
Dividend yield
Average volume
123.48K
Average volume123.48K
High today
$1.50
High today$1.50
Low today
$1.35
Low today$1.35
Open price
$1.39
Open price$1.39
Volume
185.80K
Volume185.80K
52 Week high
$35.04
52 Week high$35.04
52 Week low
$1.29
52 Week low$1.29

People also own

Based on the portfolios of people who own BTAI. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.